IFN-γ positive selected T-cells(Miltenyi)

N/A

Report date: 2024/07/03 21:31:43

Base Information

Drug NameIFN-γ positive selected T-cells(Miltenyi)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsCytomegalovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMiltenyi Biotec BV & Co KG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMiltenyi Biotec BV & Co KG
Active IndicationsN/A
Inactive IndicationsCytomegalovirus Infections

Other Information

ATC CodeN/A
Related LinksN/A